Hereditary factors in pancreatic cancer

Henry T. Lynch, Randall E. Brand, Jane F. Lynch, Ramon M. Fusaro, Scott E. Kern

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The incidence and the mortality rates for pancreatic cancer are the same, indicating its dismal outlook. Its natural history remains elusive. Cigarette smoking appears to be the most significant environmental culprit. Hereditary factors may account for approximately 5% of the total pancreatic cancer burden. However, when its extant heterogeneity and the reduced penetrance of causal germline mutations are considered, the hereditary incidence may significantly exceed this estimate. Even when endoscopic ultrasound (EUS), the gold standard for pancreatic cancer screening, is utilized, early detection with surgical cure has rarely been accomplished. Needed to ameliorate this problem is research into genetic and environmental risk factors and their interaction. The identification of tumor biomarkers which signal early pathogenetic events, thereby enabling pancreatic cancer to be diagnosed at its earliest possible stage before it has spread to regional lymph nodes or to more distant sites, will improve the outlook. We discuss our research approaches to this problem. Members of families with the p16 germline mutation will undergo EUS coupled with the collection of pancreatic juice for the study of a possible gradient for telomerase activity, K-ras mutations, and cytology. If changes in these putative biomarkers are observed, endoscopic retrograde cholangio-pancreatography (ERCP) would be the next diagnostic step. We conclude with a discussion of ethical concerns about this research.

Original languageEnglish
Pages (from-to)12-31
Number of pages20
JournalJournal of Hepato-Biliary-Pancreatic Surgery
Volume9
Issue number1
DOIs
StatePublished - 2002

Fingerprint

Pancreatic Neoplasms
Germ-Line Mutation
Pancreatic Juice
Genetic Research
Penetrance
Telomerase
Incidence
Tumor Biomarkers
Natural History
Early Detection of Cancer
Research
Cell Biology
Biomarkers
Lymph Nodes
Smoking
Mutation
Mortality

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Hereditary factors in pancreatic cancer. / Lynch, Henry T.; Brand, Randall E.; Lynch, Jane F.; Fusaro, Ramon M.; Kern, Scott E.

In: Journal of Hepato-Biliary-Pancreatic Surgery, Vol. 9, No. 1, 2002, p. 12-31.

Research output: Contribution to journalArticle

Lynch, Henry T. ; Brand, Randall E. ; Lynch, Jane F. ; Fusaro, Ramon M. ; Kern, Scott E. / Hereditary factors in pancreatic cancer. In: Journal of Hepato-Biliary-Pancreatic Surgery. 2002 ; Vol. 9, No. 1. pp. 12-31.
@article{73b1662d1e5d4fe39621c06136483240,
title = "Hereditary factors in pancreatic cancer",
abstract = "The incidence and the mortality rates for pancreatic cancer are the same, indicating its dismal outlook. Its natural history remains elusive. Cigarette smoking appears to be the most significant environmental culprit. Hereditary factors may account for approximately 5{\%} of the total pancreatic cancer burden. However, when its extant heterogeneity and the reduced penetrance of causal germline mutations are considered, the hereditary incidence may significantly exceed this estimate. Even when endoscopic ultrasound (EUS), the gold standard for pancreatic cancer screening, is utilized, early detection with surgical cure has rarely been accomplished. Needed to ameliorate this problem is research into genetic and environmental risk factors and their interaction. The identification of tumor biomarkers which signal early pathogenetic events, thereby enabling pancreatic cancer to be diagnosed at its earliest possible stage before it has spread to regional lymph nodes or to more distant sites, will improve the outlook. We discuss our research approaches to this problem. Members of families with the p16 germline mutation will undergo EUS coupled with the collection of pancreatic juice for the study of a possible gradient for telomerase activity, K-ras mutations, and cytology. If changes in these putative biomarkers are observed, endoscopic retrograde cholangio-pancreatography (ERCP) would be the next diagnostic step. We conclude with a discussion of ethical concerns about this research.",
author = "Lynch, {Henry T.} and Brand, {Randall E.} and Lynch, {Jane F.} and Fusaro, {Ramon M.} and Kern, {Scott E.}",
year = "2002",
doi = "10.1007/s005340200001",
language = "English",
volume = "9",
pages = "12--31",
journal = "Journal of Hepato-Biliary-Pancreatic Sciences",
issn = "1868-6974",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Hereditary factors in pancreatic cancer

AU - Lynch, Henry T.

AU - Brand, Randall E.

AU - Lynch, Jane F.

AU - Fusaro, Ramon M.

AU - Kern, Scott E.

PY - 2002

Y1 - 2002

N2 - The incidence and the mortality rates for pancreatic cancer are the same, indicating its dismal outlook. Its natural history remains elusive. Cigarette smoking appears to be the most significant environmental culprit. Hereditary factors may account for approximately 5% of the total pancreatic cancer burden. However, when its extant heterogeneity and the reduced penetrance of causal germline mutations are considered, the hereditary incidence may significantly exceed this estimate. Even when endoscopic ultrasound (EUS), the gold standard for pancreatic cancer screening, is utilized, early detection with surgical cure has rarely been accomplished. Needed to ameliorate this problem is research into genetic and environmental risk factors and their interaction. The identification of tumor biomarkers which signal early pathogenetic events, thereby enabling pancreatic cancer to be diagnosed at its earliest possible stage before it has spread to regional lymph nodes or to more distant sites, will improve the outlook. We discuss our research approaches to this problem. Members of families with the p16 germline mutation will undergo EUS coupled with the collection of pancreatic juice for the study of a possible gradient for telomerase activity, K-ras mutations, and cytology. If changes in these putative biomarkers are observed, endoscopic retrograde cholangio-pancreatography (ERCP) would be the next diagnostic step. We conclude with a discussion of ethical concerns about this research.

AB - The incidence and the mortality rates for pancreatic cancer are the same, indicating its dismal outlook. Its natural history remains elusive. Cigarette smoking appears to be the most significant environmental culprit. Hereditary factors may account for approximately 5% of the total pancreatic cancer burden. However, when its extant heterogeneity and the reduced penetrance of causal germline mutations are considered, the hereditary incidence may significantly exceed this estimate. Even when endoscopic ultrasound (EUS), the gold standard for pancreatic cancer screening, is utilized, early detection with surgical cure has rarely been accomplished. Needed to ameliorate this problem is research into genetic and environmental risk factors and their interaction. The identification of tumor biomarkers which signal early pathogenetic events, thereby enabling pancreatic cancer to be diagnosed at its earliest possible stage before it has spread to regional lymph nodes or to more distant sites, will improve the outlook. We discuss our research approaches to this problem. Members of families with the p16 germline mutation will undergo EUS coupled with the collection of pancreatic juice for the study of a possible gradient for telomerase activity, K-ras mutations, and cytology. If changes in these putative biomarkers are observed, endoscopic retrograde cholangio-pancreatography (ERCP) would be the next diagnostic step. We conclude with a discussion of ethical concerns about this research.

UR - http://www.scopus.com/inward/record.url?scp=0036253677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036253677&partnerID=8YFLogxK

U2 - 10.1007/s005340200001

DO - 10.1007/s005340200001

M3 - Article

VL - 9

SP - 12

EP - 31

JO - Journal of Hepato-Biliary-Pancreatic Sciences

JF - Journal of Hepato-Biliary-Pancreatic Sciences

SN - 1868-6974

IS - 1

ER -